Product Information
CUVPOSA 1 MG/5 ML SOLUTION is a brand product labeled by Merz Pharmaceuticals, LLC, priced at $1.0067 per ML under NDC 00259050116. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 28, 2010. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/5mL
Manufacturer
Merz Pharmaceuticals, LLCNDC
00259050116
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
New Drug (NDA)
FDA Application
NDA022571FDA Approved
7/28/2010
TE Code
AA
On Market Since
1/1/2013
Pharmacological Classes
Price Statistics
The NADAC for CUVPOSA 1 MG/5 ML SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0067 per ML |
|---|---|
| All-time high | $1.0174 (Sep 12, 2018) |
| All-time low | $0.7883 (Nov 28, 2013) |
| 52-week high | $1.0129 |
| 52-week low | $1.0067 |
| Median price | $1.0114 |
| Average price | $0.9917 |
| Largest weekly change | +9.9% (Dec 10, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glycopyrrolate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Merz Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CUVPOSA 1 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CUVPOSA 1 MG/5 ML SOLUTION, manufactured by Merz Pharmaceuticals, LLC, is $1.0067 per ML (NDC 00259050116), effective Sep 30, 2026.
How has the price of CUVPOSA 1 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for CUVPOSA 1 MG/5 ML SOLUTION has risen 27.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CUVPOSA 1 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for CUVPOSA 1 MG/5 ML SOLUTION has ranged from a low of $0.7883 (Nov 28, 2013) to a high of $1.0174 (Sep 12, 2018), with a median of $1.0114 per ML.
Are there cheaper alternatives to CUVPOSA 1 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CUVPOSA 1 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CUVPOSA 1 MG/5 ML SOLUTION?
CUVPOSA 1 MG/5 ML SOLUTION (NDC 00259050116) is labeled by Merz Pharmaceuticals, LLC, and CMS classifies it as a brand product.